Versatile ligand for palladium-catalyzed meta-C—H functionalizations of aromatic substrates

US10696635B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10696635-B2
Application numberUS-201716094707-A
CountryUS
Kind codeB2
Filing dateApr 18, 2017
Priority dateApr 18, 2016
Publication dateJun 30, 2020
Grant dateJun 30, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A class of mono-protected 3-amino-2-hydroxypyridine (MPAHP) ligands that enable the meta-C—H arylation of anilines, phenols, phenylacetic acids, and biologically relevant heterocyclic compounds using norbornene as a transient mediator is disclosed, such as in the formation of a reaction product of Formula IA: The applicability of this meta-arylation methodology in the pharmaceutical industry is illustrated for heteroaryl substrates and heteroaryl iodide coupling partners, a feat made possible by using the MPAHP ligand. The enabling nature of MPAHP ligands to achieve other meta-C—H functionalization processes is also illustrated by the development of a meta-C—H amination reaction and a meta-C—H alkynylation reaction.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method for preparing a compound of Formula IA: wherein: Ar is aryl or heteroaryl; Ring A is a carbocyclic ring selected from the group consisting of: or Ring A is a heterocyclic ring selected from the group consisting of: wherein: PG is selected from the group consisting of acetyl, pivaloyl, tert-butoxycarbonyl, benzyloxycarbonyl, 2,2,2-trichloroethoxycarbonyl, 9-fluorenylmethoxycarbonyl, methanesulfonyl, trifluoromethanesulfonyl, and nitrobenzenesulfonyl; * is the point of attachment to Ar; and is the point of attachment to X; Ring B is a heteroaromatic ring selected from the group consisting of: wherein: is the point of attachment to Y; X is —CH 2 —, —O—, or —N-PG-; Y is —CH 2 —; PG is benzyl or tert-butoxycarbonyl; and n is 0 or 1; wherein aryl is optionally substituted at the meta and para positions with one or two substituents independently selected from the group consisting of fluoro, chloro, bromo, iodo, nitro, cyano, C 1 -C 7 -hydrocarbyl, C 1 -C 7 -hydrocarbyl substituted by protected hydroxy, perfluoro-C 1 -C 3 -hydrocarbyl, C(O)—C 1 -C 7 -hydrocarbyl, C(O)O—C 1 -C 7 -hydrocarbyl, protected amino, di-(C 1 -C 7 -hydrocarbyl) C 1 -C 7 -hydrocarbylphosphonate, protected hydroxy, —O—C 1 -C 7 -hydrocarbyl, —S—C 1 -C 7 -hydrocarbyl, C 3 -C 7 cyclic hydrocarbyl, C 3 -C 7 cyclic hydrocarbyl substituted by protected hydroxy, and a fused ring having 3 or 4 added ring atoms; or wherein aryl is optionally substituted at the ortho position with a substituent selected from the group consisting of C(O)O—C 1 -C 7 -hydrocarbyl and NHC(O)—C 1 -C 7 -hydrocarbyl; wherein heteroaryl is optionally substituted with one or two substituents independently selected from the group consisting of fluoro, chloro, bromo, iodo, C 1 -C 7 -hydrocarbyl, perfluoro-C 1 -C 3 -hydrocarbyl, C(O)—C 1 -C 7 -hydrocarbyl, C(O)O—C 1 -C 7 -hydrocarbyl, —O—C 1 -C 7 -hydrocarbyl, —S—C 1 -C 7 -hydrocarbyl, C 3 -C 7 cyclic hydrocarbyl, and a fused ring having 3 or 4 added ring atoms in which any nitrogen atom is free of reactive hydrogens; wherein Ring A is optionally substituted with one, two or three substituents independently selected from the group consisting of fluoro, chloro, bromo, nitro, cyano, C 1 -C 7 -hydrocarbyl, perfluoro-C 1 -C 3 -hydrocarbyl, C 1 -C 7 -hydrocarbyl-4- to 6-membered ring, C(O)—C 1 -C 7 -hydrocarbyl, C(O)O—C 1 -C 7 -hydrocarbyl, protected amino, —O—C 1 -C 7 -hydrocarbyl, —S—C 1 -C 7 -hydrocarbyl, and C 3 -C 7 cyclic hydrocarbyl; wherein Ring B is optionally substituted with one, two or three substituents independently selected from the group consisting of C 1 -C 7 -hydrocarbyl, C 1 -C 3 -hydrocarbyl-CF 3 , C 1 -C 7 -hydrocarbyl-4- to 6-membered ring, —O—C 1 -C 7 -hydrocarbyl, and —O—C 1 -C 7 -hydrocarbyl-CF 3 ; and wherein the hydroxy and amino protecting groups are independently selected from the group consisting of acetyl, pivaloyl, tert-butoxycarbonyl, benzyloxycarbonyl, 2,2,2-trichloroethoxycarbonyl, 9-fluorenylmethoxycarbonyl, methanesulfonyl, trifluoromethanesulfonyl, and nitrobenzenesulfonyl; provided that: (a) when n is 0, X is —CH 2 — or —N-PG-; and (b) when n is 1, X is —O— or —N-PG-; wherein the method comprises the following steps: (A) reacting a compound of Formula I: wherein: Ring A is a carbocyclic ring selected from the group consisting of:  or Ring A is a heterocyclic ring selected from the group consisting of: wherein: PG is selected from the group consisting of acetyl, pivaloyl, tert-butoxycarbonyl, benzyloxycarbonyl, 2,2,2-trichloroethoxycarbonyl, 9-fluorenylmethoxycarbonyl, methanesulfonyl, trifluoromethanesulfonyl, and nitrobenzenesulfonyl; * is the point of attachment to Ar; and is the point of attachment to X; Ring B is a heteroaromatic ring selected from the group consisting of: wherein: is the point of attachment to Y; X is —CH 2 —, —O—, or —N-PG-; Y is —CH 2 —; PG is benzyl or tert-butoxycarbonyl; and n is 0 or 1; wherein aryl is optionally substituted at the meta and para positions with one or two substituents independently selected from the group consisting of fluoro, chloro, bromo, iodo, nitro, cyano, C 1 -C 7 -hydrocarbyl, C 1 -C 7 -hydrocarbyl substituted by protected hydroxy, perfluoro-C 1 -C 3 -hydrocarbyl, C(O)—C 1 -C 7 -hydrocarbyl, C(O)O—C 1 -C 7 -hydrocarbyl, protected amino, di-(C 1 -C 7 -hydrocarbyl) C 1 -C 7 -hydrocarbylphosphonate, protected hydroxy, —O—C 1 -C 7 -hydrocarbyl, —S—C 1 -C 7 -hydrocarbyl, C 3 -C 7 cyclic hydrocarbyl, C 3 -C 7 cyclic hydrocarbyl substituted by protected hydroxy, and a fused ring having 3 or 4 added ring atoms; or wherein aryl is optionally substituted at the ortho position with a substituent selected from the group consisting of C(O)O—C 1 -C 7 -hydrocarbyl and NHC(O)—C 1 -C 7 -hydrocarbyl; wherein heteroaryl is optionally substituted with one or two substituents independently selected from the group consisting of fluoro, chloro, bromo, iodo, C 1 -C 7 -hydrocarbyl, perfluoro-C 1 -C 3 -hydrocarbyl, C(O)—C 1 -C 7 -hydrocarbyl, C(O)O—C 1 -C 7 -hydrocarbyl, —O—C 1 -C 7 -hydrocarbyl, —S—C 1 -C 7 -hydrocarbyl, C 3 -C 7 cyclic hydrocarbyl, and a fused ring having 3 or 4 added ring atoms in which any nitrogen atom is free of reactive hydrogens; wherein Ring A is optionally substituted with one, two or three substituents independently selected from the group consisting of fluoro, chloro, bromo, nitro, cyano, C 1 -C 7 -hydrocarbyl, perfluoro-C 1 -C 3 -hydrocarbyl, C 1 -C 7 -hydrocarbyl-4- to 6-membered ring, C(O)—C 1 -C 7 -hydrocarbyl, C(O)O—C 1 -C 7 -hydrocarbyl, protected amino, —O—C 1 -C 7 -hydrocarbyl, —S—C 1 -C 7 -hydrocarbyl, and C 3 -C 7 cyclic hydrocarbyl; wherein Ring B is optionally substituted with one, two or three substituents independently selected from the group consisting of C 1 -C 7 -hydrocarbyl, C 1 -C 3 -hydrocarbyl-CF 3 , C 1 -C 7 -hydrocarbyl-4- to 6-membered ring, —O—C 1 -C 7 -hydrocarbyl, and —O—C 1 -C 7 -hydrocarbyl-CF 3 ; and wherein the hydroxy and amino protecting groups are independently selected from the group consisting of acetyl, pivaloyl, tert-butoxycarbonyl, benzyloxycarbonyl, 2,2,2-trichloroethoxycarbonyl, 9-fluorenylmethoxycarbonyl, methanesulfonyl, trifluoromethanesulfonyl, and nitrobenzenesulfonyl; provided that: (a) when n is 0, X is —CH 2 — or —N-PG-; and (b) when n is 1, X is —O— or —N-PG-; with: (i) Pd(OAc) 2 ; and (ii) a ligand of Formula III: wherein:  R 15 is —C(O)—C 1 -C 11 hydrocarbyl or perfl

Assignees

Inventors

Classifications

  • with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring · CPC title

  • Radicals substituted by singly-bound nitrogen atoms (nitro radicals C07D213/26) · CPC title

  • with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms · CPC title

  • Radicals substituted by halogen atoms or nitro radicals · CPC title

  • linked by a chain containing hetero atoms as chain links · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10696635B2 cover?
A class of mono-protected 3-amino-2-hydroxypyridine (MPAHP) ligands that enable the meta-C—H arylation of anilines, phenols, phenylacetic acids, and biologically relevant heterocyclic compounds using norbornene as a transient mediator is disclosed, such as in the formation of a reaction product of Formula IA: …
Who is the assignee on this patent?
Scripps Research Inst
What technology area does this patent fall under?
Primary CPC classification C07D213/68. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jun 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).